06:10 AM EDT, 05/06/2024 (MT Newswires) -- Serina Therapeutics ( SER ) on Friday filed a registration statement for the potential offering of up to about 3 million common shares issuable upon warrant exercises, and up to about 1.5 million warrants to purchase common shares.

The prospectus also covers the sale by certain selling shareholders of up to about 4.2 million common shares, including about 1.9 million outstanding shares.

The company intends to use its portion of the net proceeds from the potential sale for working capital and general corporate purposes.